1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA SENP6 CTRPv2 pan-cancer AAC 0.14 2e-05
mRNA POLDIP3 CTRPv2 pan-cancer AAC 0.15 2e-05
mRNA HIST1H4H CTRPv2 pan-cancer AAC -0.14 2e-05
mRNA FBXW7 CTRPv2 pan-cancer AAC 0.15 2e-05
mRNA DYRK1B CTRPv2 pan-cancer AAC 0.14 2e-05
mRNA PDP1 CTRPv2 pan-cancer AAC -0.14 2e-05
mRNA KBTBD6 CTRPv2 pan-cancer AAC 0.14 2e-05
mRNA SMIM17 CTRPv2 pan-cancer AAC 0.14 2e-05
mRNA RIF1 CTRPv2 pan-cancer AAC 0.14 2e-05
mRNA IQCB1 CTRPv2 pan-cancer AAC 0.17 2e-05
Download CSV